- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Delcath Systems Inc (DCTH)
The Delcath Systems share price today is 12.610, view NASDAQ DCTH stock exchange data. Track the latest Delcath Systems share price with real-time updates on DCTH stock performance including market cap, day range, 52-week range and dividend yield. Access DCTH charts, earnings dates and analyst estimates to support your investment decisions.
12.610
-0.340(-2.63%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.603
12.920
52 wk Range
8.120
13.550
DCTH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.60312.920
52 wk Range
8.12013.550
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DCTH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
21.352
Upside
+69.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Form 8K Delcath Systems Inc For: 7 May
- Investing.com
- Form 8K Delcath Systems Inc For: 14 May
- Investing.com
- Form 8K Delcath Systems Inc For: 14 May
- Investing.com
- Form 10Q Delcath Systems Inc For: 7 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 21.352
(+69.33% Upside)
Delcath Systems Inc Earnings Call Summary for Q1/2026
- Delcath Systems Q1 2026 revenue reached $25M, up 26.3% YoY, beating forecast of $23.51M; EPS of -$0.03 topped estimates by 70%.
- HEPZATO KIT drove 93.2% of revenue with 86% gross margin; company posted $1.1M net loss versus $1.1M income in Q1 2025.
- Stock rose 1.95% pre-market to $11.48 following earnings beat; shares up 32% over six months with analyst targets reaching $29.76.
- Company revised 2026 guidance, lowering active metastatic uveal melanoma treatment center target to 37 from previous projections.
- CEO Padia emphasized expanding treatment network and commercial footprint; CHOPIN trial results driving increased physician adoption of therapies.
Last Updated: 14-05-2026, 01:04 am
Read Full TranscriptEarnings
Latest Release
07-05-2026
EPS / Forecast
-0.03 / -0.10
Revenue / Forecast
25M / 23.51M
Compare DCTH to Peers and Sector
Metrics to compare | DCTH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDCTHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 795.0x | −13.0x | −0.4x | |
PEG Ratio | 7.73 | −0.36 | 0.00 | |
Price/Book | 4.0x | 4.7x | 2.6x | |
Price / LTM Sales | 4.9x | 3.7x | 3.0x | |
Upside (Analyst Target) | 62.2% | 55.6% | 51.8% | |
Fair Value Upside | Unlock | 9.0% | 7.2% | Unlock |
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Delcath Systems (DCTH) Share Price Today?
The Delcath Systems share price today is 12.610.
What is the current Delcath Systems (DCTH) share price and day range?
As of 30-06-2026, the Delcath Systems share price is 12.610, with a previous close of 12.950. The share price has ranged from 12.603 to 12.920 today, while the 52-week range spans from 8.120 to 13.550.
What Is the Delcath Systems Market Cap?
As of today, Delcath Systems market cap is 441.530M.
What Is the Delcath Systems (DCTH) Share Price Target?
The average 12-month share price target for Delcath Systems is 21.352, with a high estimate of 29.76 and a low estimate of 16. 5 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +69.33% Upside potential.
What Is Delcath Systems's Earnings Per Share (TTM)?
The Delcath Systems EPS (TTM) is 0.014.
When Is the Next Delcath Systems Earnings Date?
Delcath Systems will release its next earnings report on 10-08-2026.
From a Technical Analysis Perspective, Is DCTH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Delcath Systems Trade On?
Delcath Systems is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Delcath Systems?
The stock symbol for Delcath Systems is "DCTH."
How Many Times Has Delcath Systems Stock Split?
Delcath Systems has split 5 times.
How Many Employees Does Delcath Systems Have?
Delcath Systems has 156 employees.
What Is the DCTH Premarket Price?
DCTH's last pre-market stock price is 13.180. The pre-market share volume is 100.000, and the stock has changed by 0.230, or 1.780%.
What Is the DCTH After Hours Price?
DCTH's last after hours stock price is 13.150, the stock has changed by 0.200, or 1.540%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.